GSK Plc (GSK)

58.35 +1.22 (+2.14%) USD  |  NYSE  |  Apr 17, 16:00
58.34 0.00 (0.00%) Pre-Market: 20:00
More

GSK SG&A Expense (Quarterly) : 3.510B for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 152.78M
Biodexa Pharmaceuticals Plc --
Novavax, Inc. 34.12M
BioNTech SE 253.62M
Moderna, Inc. 308.00M